Avrio Biopharmaceuticals Appoints David L. Gelber to Director of Manufacturing
Published: Jun 29, 2010
"We are excited to have David join Avrio. He is passionate about serving our customers and dedicated to operational excellence," said CEO and Founder, Dr. Assad J. Kazeminy. "David's experience and leadership skills exhibit our commitment to scientific excellence, leading-edge resources, and dependable customer care."
Mr. Gelber has over 25 years of experience with production and project management, and has demonstrated knowledge of all areas of aseptic pharmaceutical manufacturing. David has extensive experience serving as the manufacturing and operations head for both contract and commercial manufacturing operations. His previous work experience includes serving as the Director of Operations for AAI Development Services, as well as holding a similar sales and management role for B. Braun Medical, Inc.
"David offers our clients solutions to their problems and peace of mind that we'll deliver as promised and we are confident that the future for Avrio is very promising," said Yvonne Verburgt, Vice President of Business Development and Marketing.
To learn more about how Avrio is growing to accommodate client needs, visit www.avriobiopharma.com or call: 866-98-AVRIO.
About Avrio Biopharmaceuticals, LLC
Avrio Biopharma, an affiliate of Irvine Pharmaceutical Services, is a premier contract manufacturing lab providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Avrio, along with its Irvine affiliate, offers full cGMP product development support, specializing in preformulation/formulation, analytical development, process validation, scale-up studies, packaging and labeling, stability testing and complete analytical CMC testing. Learn more at www.avriobiopharma.com or call 866-98-AVRIO (866-982-8746).
SOURCE Avrio Biopharmaceuticals, LLC